丙型肝炎是肝癌发生的主要病因之一. 随着直接抗病毒药物的应用, 95% 以上的患者可根除HCV
, 获得持续病毒学应答(SVR). 有效的抗病毒治疗可以改变丙型肝炎的自然病程 …

Objective Patients with 'late presentation'(LP) of chronic hepatitis C infection (HCV) have
already developed advanced liver disease before receiving direct-acting antiviral (DAA) …

目的观察采用经皮肝穿刺胆道引流(PTBD) 联合体外辅助胆汁入肠治疗恶性梗阻性黄疸患者的
疗效. 方法2019 年9 月~ 2022 年9 月我院诊治的恶性梗阻性黄疸患者100 例(其中胆管细胞癌42 …

三期增强CT 扫描联合血清AFP 和VEGF 水平诊断肝细胞癌患者临床研究∗ Page 1 ∗ 基金项目:
中国生物技术发展中心研究项目( 编号: 2019YFC0118100) 作者单位:110001 沈阳市中国医科 …

Chronic hepatitis C virus infection is still one of the major risk factors for the development of
hepatocellular carcinoma (HCC), the most frequent type of primary liver cancer. Direct-acting …

We would like to thank Dr. Nakatsuka and colleagues 1 for their interest in our previously
proposed 2 algorithms for de novo hepatocellular carcinoma (HCC) risk stratification in …

Background Previous studies show the uptake of biannual ultrasound (US) surveillance in
patients with cirrhosis is suboptimal. Here, our goal was to understand in broader terms how …

Significant advances into the genetics of alcohol-related liver disease (ALD) have been
made in the last two decades. Most notably, this includes the discovery of ten common …

Background and Aims The liver cancer risk test (LCR1-LCR2) is a multianalyte blood test
combining proteins involved in liver cell repair (apolipoprotein A1, haptoglobin) …

Small cell carcinoma of the rectum (SCCR) is a rare and aggressive neuroendocrine tumor.
Its association with a tubulovillous adenoma is an exceptional occurrence, presenting …